Pertussis Vaccines: Whole-cell & Acellular Vaccines, Different Types & Manufacturers along with the Regimen in Various Age Groups

Infectious Diseases

Evaluating the Rising Demand & the Market P...

In recent years, the demand for Omega-3 Products has risen exponentially. Omega-3 fatty acids are also referred to as Polyunsaturated fatty acids and work in the body to lower triglycerides, reduce...

May 31, 2023

Pharma News and Updates for GSK, Gilead, ProMIS, Nucleix, PharmaTher, Vedanta Biosciences
FDA Approves GSK’s Arexvy for RSV; CHMP’s Opinion on Gilead’s Hepcludex® for HDV; FDA Clearance to ProMIS’s IND Application for PMN310; FDA Grants 501K Clearance to Bladder EpiCheck; PharmaTher Submits Fast Track Application for Ketarx to US FDA; Fast Track Designation to Vedanta Biosciences’ VE303

FDA Approves GSK’s Arexvy, the First RSV Vaccine for Older Adults GSK plc stated that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by a respiratory syncytial virus (RSV) in peopl...

Find More
gsk-respiratory-syncytial-virus-vaccine
GSK Is All Set To Launch Respiratory Syncytial Virus Vaccine… Now Who’s Next?

Infections due to respiratory syncytial virus (RSV) have seriously troubled drug makers for decades and the need for a vaccine was on since the 1960s. According to the assessment done by DelveInsight on the latest published “Respiratory Syncytial Virus Epidemiology Report,” it is estimated to affect approximately 5...

Find More
emerging-vaccines-for-respiratory-syncytial-virus-treatment
Respiratory Syncytial Virus Treatment Market: A Complex Space Worth Billions!

Respiratory syncytial virus is estimated to affect approximately 5 million cases this year in the United States and 2.5 million RSV cases in the EU4 countries and the United Kingdom. As per Delveinsight analysis on the latest published “Respiratory Syncytial Virus Epidemiology Report,” the US comprised ~70%, ~27%, ...

Find More

More Views & Analysis

epstein-barr-virus-ebv-treatment-outlook
Changing Landscape of EBV-associated Diseases Treatment: Is T-cell Immunotherapy the Answer?

Epstein–Barr virus (EBV), also known as human herpesvirus 4 (HHV-4), was discovered in the 1960s as an inescapable virus that infects almost 95% of the world’s population and causes nearly 1% of all cancers. Besides, the virus is a leading cause of infectious mononucleosis (IM) and is associated with different subt...

Find More

Biologics in the Nasal Polyposis Treatment Market
Biologics Spark Market Interest In The Nasal Polyposis Treatment Space

A highly prevalent condition, Nasal polyps are benign growths in the mucosa of the nose that blocks the nasal passageway, reducing the quality of life (QoL), causing hyposmia or anosmia and sleep disturbances in those affected. Often associated with chronic nasal inflammation and conditions like asthma, these are a...

Find More

mercks-gefapixant-for-crc-treatment
Will Merck’s P2X3 Receptor Antagonist for Chronic Refractory Cough Treatment Be Able to Turn FDA’s Nay Into Yea?

Patients who are battling this crippling ailment find that chronic refractory cough (CRC), also known as refractory chronic cough (RCC) or unexplained chronic cough (UCC), proves to be a major burden. DelveInsight’s analysis estimates that in the US, there were approximately 12.7 million 12-month prevalent episodes...

Find More

emerging-vaccines-for-clostridium-difficile-infection-treatment
Innovative Vaccines for Clostridium difficile Infection Treatment in the Horizon

Clostridium difficile infection (CDI) has emerged as a significant nosocomial infection over the years with increased incidence, recurrence and need for hospitalization. About 15% to 30% of patients who initially respond to antimicrobial therapy experience recurrent CDI (rCDI). After the first recurrence, the risk ...

Find More

uncomplicated-uti-treatment-landscape
Uncomplicated UTI Treatment: Challenges and Opportunities in the Market

Urinary tract infection (UTI), also known as acute cystitis, is an infection in any part of the urinary system, including the kidneys, bladder, ureters, and urethra. It is one of the most common infections in local primary care, and UTIs are among the most frequently encountered infections in the outpatient setting...

Find More

osteomyelitis-treatment-outlook
Osteomyelitis Treatment Market: Evaluating the New Line of Therapies in the Therapeutics Space

A bone marrow infection that tends to spread and frequently involves periosteal tissues and nearby cortical plates is known as osteomyelitis. It might be acute, subacute, or chronic. In most cases, acute osteomyelitis is hematogenous in origin, has a recent onset, and has a brief duration. It can also be brought on...

Find More

It was assumed initially that Alzheimer’s Disease was a rare condition, but now it is considered t.....

Find More

Wet Age-related Macular Degeneration (Wet-AMD) also referred to as Neovascular AMD (nAMD), is the mo.....

Find More

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of .....

Find More

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Find More

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from .....

Find More

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally .....

Find More